nach oben

Reactions Weekly

Erschienen in:

01.05.2012 | Case report

Adalimumab

Transient fever in a child: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Excerpt

A 12.5-year-old girl started receiving subcutaneous adalimumab for ulcerative colitis. The drug was administered for at least 6 months and the initial dosage was 80mg and, thereafter, 40mg every 2 weeks. She developed a transient fever a few hours after receiving an injection of the drug [duration of treatment to reaction onset and outcome not stated].Author Comment“[The patient] showed a minor adverse effect probably related to [adalimumab] administration“. …

Romagnoli V, Gatti S, Catassi C.Short term response to adalimumab in children affected with ulcerative colitis. Digestive and Liver Disease 43: S423 abstr. PP31, Oct 2011 - Italy

Titel: Adalimumab
Transient fever in a child: case report
Publikationsdatum: 01.05.2012
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2012
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.2165/00128415-201214020-00017

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Adalimumab

Transient fever in a child: case report

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2012

Amiodarone

Baclofen withdrawal

Ibuprofen

Human papillomavirus vaccine recombinant quadrivalent

Dabigatran etexilate

Sunitinib